Format

Send to

Choose Destination
Infect Dis Clin North Am. 2003 Jun;17(2):243-59.

Emerging antibiotic resistance in urinary tract pathogens.

Author information

1
Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, BB1221, Box 356523, Seattle, WA 98195, USA. kalg@u.washington.edu

Abstract

In vitro antimicrobial resistance is an evolving and growing problem in UTI. Much of the increase is occurring in acute uncomplicated cystitis, an infection that has traditionally been simple to treat. The current trend of rising TMP-SMX and beta-lactam resistance rates is worrisome. Of more concern, however, are the emerging issues of fluoroquinolone resistance and MDR among community-acquired urinary isolates. Judicious use of antibiotics and development of novel nonantimicrobial-based methods of prevention of UTI are important strategies to help slow the progression of resistance. In the meantime, ongoing surveillance of resistance trends and enhanced understanding of the determinants of resistance are crucial for optimal management of UTIs.

PMID:
12848469
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center